FDA Import Refusal 8JB-0093850-4/11/39 — Teva Pharmaceuticals USA, Inc
The FDA refused shipment 8JB-0093850-4/11/39 from Teva Pharmaceuticals USA, Inc (United States) on March 22, 2023. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 22, 2023
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62YDA07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
- Charges
- 179